½ÃÀ庸°í¼­
»óǰÄÚµå
1596463

¼¼°èÀÇ ½½¶óÀÌµå ¿°»ö±â ½ÃÀå : Á¦Ç°º°, ±â¼úº°, ÃÖÁ¾ »ç¿ëÀÚº° - ¿¹Ãø(2025-2030³â)

Slide Stainer Market by Product (Consumables & Accessories, Equipment, Reagents), Technology (Cytology, Hematology, Hematoxylin & Eosin), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

½½¶óÀÌµå ¿°»ö±â ½ÃÀåÀº 2023³â¿¡ 3¾ï 9,284¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 4¾ï 2,483¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 8.23%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 6¾ï 8,375¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½½¶óÀÌµå ¿°»ö±â ½ÃÀåÀº Çö¹Ì°æ ºÐ¼®À» À§ÇØ ½½¶óÀ̵带 ¿°»öÇÏ´Â °úÁ¤À» ÀÚµ¿È­ÇÏ´Â ¿ªÇÒ¿¡ ÀÇÇØ Á¤ÀǵǸç Áø´Ü ½ÇÇè½Ç, º´¿ø ¹× ¿¬±¸ ±â°ü¿¡ ÇʼöÀûÀÔ´Ï´Ù. ½½¶óÀÌµå ¿°»ö±âÀÇ Çʿ伺Àº ÀϰüµÇ°í Á¤È®ÇÑ ¿°»öÀ» ¼öÇàÇÏ´Â ´É·Â¿¡ ÀÖ¾î ÀÇ·áÁø´Ü°ú ¿¬±¸ ¿ëµµ¿¡¼­ÀÇ ¿öÅ©Ç÷οìÀÇ È¿À²°ú Á¤¹Ðµµ¸¦ ´ëÆø Çâ»ó½Ãŵ´Ï´Ù. º´¸®Á¶Á÷ÇÐ, ¼¼Æ÷ÇÐ, ¹Ì»ý¹°ÇÐ ºÐ¾ß¿¡¼­ ÁÖ·Î »ç¿ëµÇ´Â ÀÌ ÀåÄ¡µéÀº ÀÏ»óÀûÀÎ ¿°»öºÎÅÍ Æ¯¼öÇÑ ¿°»ö±îÁö Æø³Ð°Ô ´ëÀÀÇÕ´Ï´Ù. ´Ù·®ÀÇ »ùÇÿ¡ ÀÇÇÑ ÀÚµ¿È­ ¼ö¿ä Áõ°¡, ¸ÂÃãÇü ÀÇ·á ÁøÈ­, Áø´Ü Á¤È®µµ Çâ»ó¿¡ ´ëÇÑ ¿ä±¸´Â ½½¶óÀÌµå ¿°»ö±â ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ÃֽŠºñÁî´Ï½º ±âȸ´Â ¾Æ½Ã¾Æ ÅÂÆò¾ç°ú ¶óƾ ¾Æ¸Þ¸®Ä« µî ÇコÄɾî ÀÎÇÁ¶óÀÇ È®ÀåÀÌ ÁøÇàµÇ°í ÀÖ´Â Áö¿ª¿¡¼­ ź»ýÇϰí ÀÖ½À´Ï´Ù. Á¦Á¶»ç´Â AI³ª ±â°èÇнÀ°ú °°Àº °í±Þ ±â´ÉÀ» ÅëÇÕÇØ ¿°»ö Á¤È®µµ¿Í ºÐ¼®À» ´õ¿í ¼¼·ÃµÇ°Ô ÇÏ´Â µ¥ ÁÖ·ÂÇØ ½º¸¶Æ®·¦ ±â¼úÀÇ °íÁ¶ ¹°°áÀ» Å» ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä °úÁ¦´Â ±â¼úÀûÀ¸·Î °íµµÀÇ ½½¶óÀÌµå ¿°»ö±âÀÇ µµÀÔ°ú °ü·ÃµÈ Ãʱ⠺ñ¿ëÀÇ ³ôÀÌ¿Í ´Ù¾çÇÑ ½ÇÇè½Ç ¼³Á¤ °£ÀÇ È£È¯¼º ¹®Á¦ÀÔ´Ï´Ù. °Ô´Ù°¡ ¾ö°ÝÇÑ ±ÔÁ¦È¯°æ°ú ¹ßÀüµµ»ó Áö¿ª¿¡¼­ÀÇ Ã¤¿ë·ü Áö¿¬Àº Ãß°¡ÀûÀÎ Àå¾Ö¹°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÄÄÆÑÆ®ÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¸ðµ¨ Çõ½Å, ½Ã¾à ó¹æ °­È­, »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º °³¹ß, ¿¬±¸ ¹× ºñÁî´Ï½º ¼ºÀåÀ» À§ÇÑ ½ÇÇà °¡´É ¼ö´ÜÀ» Á¦°øÇÕ´Ï´Ù. ±â¾÷Àº ÀÇ·á ºÐ¾ßÀÇ ÁÖ¿ä ±â¾÷°úÀÇ Çù·Â ÆÄÆ®³Ê½ÊÀ» °í·ÁÇÏ¿© ±â¼úÀ» ¹ßÀü½ÃŰ°í ´õ ±¤¹üÀ§ÇÑ ½ÃÀå¿¡ ÁøÃâ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº °æÀïÀûÀÎ ¼ºÁúÀ» º¸ÀÌ¸ç ´ëÇü ±â¾÷°ú Æ´»õ Àü¹®°¡°¡ È¥ÀçµÇ¾î ±â¼úÀûÀÎ µ¹ÆÄ¿Í ¾÷¹« È¿À² Çâ»ó¿¡ ²÷ÀÓ¾øÀÌ Èû¾²°í ÀÖ½À´Ï´Ù. ÀüüÀûÀ¸·Î´Â ±â¼úÀÇ Áøº¸¿Í ·¦ÀÇ ÀÚµ¿È­¿Í È¿À²¼º Çâ»ó¿¡ ´ëÇÑ ¼¼°èÀÇ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¼ºÀå ±âȸ°¡ ÃÊ·¡µÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 3¾ï 9,284¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 4¾ï 2,483¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 6¾ï 8,375¸¸ ´Þ·¯
CAGR(%) 8.23%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ½½¶óÀÌµå ¿°»ö±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

½½¶óÀÌµå ¿°»ö±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °¨¿°Áõ ¹× ±âŸ ¸¸¼º ÁúȯÀÇ ¸¸¿¬°ú ±× ±Ùº»ÀûÀÎ ¿øÀÎ ±Ô¸íÀÇ Çʿ伺 °íÁ¶
    • ¼¼Æ÷ ¹Ì»ý¹°ÇÐÀÇ ¹ßÀü
    • º´¿øÀ̳ª Áø´Ü¼¾ÅÍ¿¡¼­ÀÇ ½½¶óÀÌµå ¿°»ö±â ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • Áø´Ü ½ÇÇè½Ç ÀÚµ¿È­
    • ½½¶óÀÌµå ¿°»ö±â¿¡¼­ÀÇ ¹ÙÄÚµå ½ºÄµ ±â´ÉÀÇ ÀÌ¿ë °¡´É¼º
  • ½ÃÀåÀÇ °úÁ¦
    • ½½¶óÀÌµå ¿°»ö±âÀÇ Æ®·¯ºí ½´ÆÃ°ú ºÒÃæºÐÇÑ ¸ÞÀÎÅͳͽº¿¡ °üÇÑ ¹®Á¦

Porter's Five Forces : ½½¶óÀÌµå ¿°»ö±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ½½¶óÀÌµå ¿°»ö±â ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ½½¶óÀÌµå ¿°»ö±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ½½¶óÀÌµå ¿°»ö±â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

½½¶óÀÌµå ¿°»ö±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ½½¶óÀÌµå ¿°»ö±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ½½¶óÀÌµå ¿°»ö±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ½½¶óÀÌµå ¿°»ö±â ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

½½¶óÀÌµå ¿°»ö±â ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °¨¿°Áõ ¹× ±âŸ ¸¸¼º Áúȯ Áõ°¡¿Í ±Ùº»ÀûÀÎ ¿øÀÎ ¹ß°ßÀÇ Çʿ伺
      • ¼¼Æ÷ ¹Ì»ý¹°ÇÐÀÇ ¹ßÀü
      • º´¿øÀ̳ª Áø´Ü¼¾ÅÍ¿¡¼­ ½½¶óÀÌµå ¿°»ö±â ¼ö¿ä Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ÇÑÁ¤µÈ ¼÷·ÃµÈ ÈÆ·ÃÀ» ¹ÞÀº Àü¹®°¡
    • ±âȸ
      • Áø´Ü ½ÇÇè½Ç ÀÚµ¿È­
      • ½½¶óÀÌµå ¿°»ö±â¿¡ À־ÀÇ ¹ÙÄÚµå ½ºÄµ ±â´ÉÀÇ °¡¿ë¼º
    • °úÁ¦
      • ½½¶óÀÌµå ¿°»ö±âÀÇ ¹®Á¦ ÇØ°á ¹× ºÎÀûÀýÇÑ À¯Áöº¸¼ö¿Í °ü·ÃµÈ ¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ½½¶óÀÌµå ¿°»ö±â ½ÃÀå : Á¦Ç°º°

  • ¼Ò¸ðǰ ¹× ¾×¼¼¼­¸®
  • ÀåÄ¡
    • ÀÚµ¿ ½½¶óÀÌµå ¿°»ö±â
    • ¼öµ¿ ½½¶óÀÌµå ¿°»ö±â
  • ½Ã¾à

Á¦7Àå ½½¶óÀÌµå ¿°»ö±â ½ÃÀå : ±â¼úº°

  • ¼¼Æ÷ÇÐ
  • Ç÷¾×ÇÐ
  • Ç츶Åå½Ç¸° ¹× ¿¡¿À½Å
  • ¸é¿ªÁ¶Á÷È­ÇÐ
  • ÀλçÀÌÃò ÇÏÀ̺긮µåÈ­
  • ¹Ì»ý¹°ÇÐ
  • Ư¼ö ¿°»ö

Á¦8Àå ½½¶óÀÌµå ¿°»ö±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Çмú¿¬±¸±â°ü
  • º´¿ø ¹× Áø´Ü ½ÇÇè½Ç
  • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ½½¶óÀÌµå ¿°»ö±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½½¶óÀÌµå ¿°»ö±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½½¶óÀÌµå ¿°»ö±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Agilent Technologies, Inc.
  • Avantik
  • Biocare Medical
  • Biogenex
  • BioMerieux Inc.
  • Cardinal Health, Inc.
  • Elitech Group
  • EMC
  • F. Hoffmann-La Roche Ltd.
  • IUL
  • Medimeas
  • Merck Group
  • Rankin Warehouse
  • SLEE Medical GmBH
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • VWR International LLC
AJY 24.12.02

The Slide Stainer Market was valued at USD 392.84 million in 2023, expected to reach USD 424.83 million in 2024, and is projected to grow at a CAGR of 8.23%, to USD 683.75 million by 2030.

The slide stainer market is defined by its role in automating the process of applying stains to slides for microscopic analysis, which is essential for diagnostic laboratories, hospitals, and research institutions. The necessity of slide stainers lies in their ability to deliver consistent and accurate staining, greatly enhancing workflow efficiency and precision in medical diagnostics and research applications. End-used predominantly in histopathology, cytology, and microbiology settings, these devices facilitate a range of routine and specialized staining procedures. Growing demand for automation due to high sample volumes, the evolution of personalized medicine, and the requirement for improved diagnostic accuracy are key factors influencing growth in the slide stainer market. The latest opportunities are emerging in regions experiencing healthcare infrastructure expansions, such as Asia-Pacific and Latin America. Manufacturers can focus on integrating advanced features like AI and machine learning to further refine staining precision and analytics, tapping into the growing wave of smart lab technologies. A significant challenge for market growth is the high initial cost associated with acquiring technologically advanced slide stainers and compatibility issues across diverse lab setups. Additionally, the stringent regulatory environment and the slow adoption rate in developing regions pose additional hurdles. Innovations in compact and cost-effective models, enhancements in reagent formulations, and user-friendly interface development present viable avenues for research and business growth. Companies can look into collaborative partnerships with key players in the healthcare sector to advance technology and reach broader markets. The market exhibits a competitive nature, with a mix of large players and niche specialists continuously striving for technological breakthroughs and operational efficiencies. Overall, the landscape presents a ripe opportunity for growth, driven by technological advancements and the increasing global emphasis on improved lab automation and efficiency.

KEY MARKET STATISTICS
Base Year [2023] USD 392.84 million
Estimated Year [2024] USD 424.83 million
Forecast Year [2030] USD 683.75 million
CAGR (%) 8.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Slide Stainer Market

The Slide Stainer Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of infectious and other chronic diseases and the need to find the underlying cause
    • Development in cell microbiology
    • Rising demand for slide strainers in hospitals and diagnostic centers
  • Market Restraints
    • Limited skilled and trained professional
  • Market Opportunities
    • Automation in the diagnostic laboratories
    • Availability of barcode scanning features in slide stainers
  • Market Challenges
    • Issues related to troubleshooting and inadequate maintenance of the slide strainer

Porter's Five Forces: A Strategic Tool for Navigating the Slide Stainer Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Slide Stainer Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Slide Stainer Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Slide Stainer Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Slide Stainer Market

A detailed market share analysis in the Slide Stainer Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Slide Stainer Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Slide Stainer Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Slide Stainer Market

A strategic analysis of the Slide Stainer Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Slide Stainer Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Avantik, Biocare Medical, Biogenex, BioMerieux Inc., Cardinal Health, Inc., Elitech Group, EMC, F. Hoffmann-La Roche Ltd., IUL, Medimeas, Merck Group, Rankin Warehouse, SLEE Medical GmBH, Sysmex Corporation, Thermo Fisher Scientific Inc., and VWR International LLC.

Market Segmentation & Coverage

This research report categorizes the Slide Stainer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables & Accessories, Equipment, and Reagents. The Equipment is further studied across Automated Slide Stainers and Manual Slide Staining Sets.
  • Based on Technology, market is studied across Cytology, Hematology, Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, and Special Staining.
  • Based on End User, market is studied across Academic and Research Institutes, Hospitals and Diagnostic Laboratories, and Pharmaceutical and Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of infectious and other chronic diseases and the need to find the underlying cause
      • 5.1.1.2. Development in cell microbiology
      • 5.1.1.3. Rising demand for slide strainers in hospitals and diagnostic centers
    • 5.1.2. Restraints
      • 5.1.2.1. Limited skilled and trained professional
    • 5.1.3. Opportunities
      • 5.1.3.1. Automation in the diagnostic laboratories
      • 5.1.3.2. Availability of barcode scanning features in slide stainers
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to troubleshooting and inadequate maintenance of the slide strainer
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Slide Stainer Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables & Accessories
  • 6.3. Equipment
    • 6.3.1. Automated Slide Stainers
    • 6.3.2. Manual Slide Staining Sets
  • 6.4. Reagents

7. Slide Stainer Market, by Technology

  • 7.1. Introduction
  • 7.2. Cytology
  • 7.3. Hematology
  • 7.4. Hematoxylin & Eosin
  • 7.5. Immunohistochemistry
  • 7.6. In Situ Hybridization
  • 7.7. Microbiology
  • 7.8. Special Staining

8. Slide Stainer Market, by End User

  • 8.1. Introduction
  • 8.2. Academic and Research Institutes
  • 8.3. Hospitals and Diagnostic Laboratories
  • 8.4. Pharmaceutical and Biotechnology Companies

9. Americas Slide Stainer Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Slide Stainer Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Slide Stainer Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Avantik
  • 3. Biocare Medical
  • 4. Biogenex
  • 5. BioMerieux Inc.
  • 6. Cardinal Health, Inc.
  • 7. Elitech Group
  • 8. EMC
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. IUL
  • 11. Medimeas
  • 12. Merck Group
  • 13. Rankin Warehouse
  • 14. SLEE Medical GmBH
  • 15. Sysmex Corporation
  • 16. Thermo Fisher Scientific Inc.
  • 17. VWR International LLC
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦